Dextech Medical AB (NGM: DEX)
Sweden
· Delayed Price · Currency is SEK 4.540
-0.280 (-5.81%)
At close: Sep 6, 2024
Dextech Medical AB Statistics
Total Valuation
Dextech Medical AB has a market cap or net worth of SEK 83.93 million. The enterprise value is 64.88 million.
| Market Cap | 83.93M |
| Enterprise Value | 64.88M |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Dextech Medical AB has 18.49 million shares outstanding. The number of shares has increased by 0.68% in one year.
| Shares Outstanding | 18.49M |
| Shares Change (YoY) | +0.68% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 55.25% |
| Owned by Institutions (%) | n/a |
| Float | 7.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.59 |
| PB Ratio | 2.83 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.79 |
| EV / Sales | 12.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.08
| Current Ratio | 20.08 |
| Quick Ratio | 20.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -14.72% and return on invested capital (ROIC) is -10.85%.
| Return on Equity (ROE) | -14.72% |
| Return on Assets (ROA) | -10.57% |
| Return on Capital (ROIC) | -10.85% |
| Revenue Per Employee | 5.39M |
| Profits Per Employee | -4.71M |
| Employee Count | 1 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 4.15 |
| 200-Day Moving Average | 4.88 |
| Relative Strength Index (RSI) | 53.66 |
| Average Volume (20 Days) | 6,064 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dextech Medical AB had revenue of SEK 5.39 million and -4.71 million in losses. Loss per share was -0.25.
| Revenue | 5.39M |
| Gross Profit | 5.45M |
| Operating Income | -5.55M |
| Pretax Income | -4.71M |
| Net Income | -4.71M |
| EBITDA | -1.85M |
| EBIT | -5.55M |
| Loss Per Share | -0.25 |
Balance Sheet
| Cash & Cash Equivalents | 19.04M |
| Total Debt | n/a |
| Net Cash | 19.04M |
| Net Cash Per Share | 1.03 |
| Equity (Book Value) | 29.61M |
| Book Value Per Share | 1.60 |
| Working Capital | 18.70M |
Cash Flow
| Operating Cash Flow | -808,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 101.23%, with operating and profit margins of -103.05% and -87.39%.
| Gross Margin | 101.23% |
| Operating Margin | -103.05% |
| Pretax Margin | -87.39% |
| Profit Margin | -87.39% |
| EBITDA Margin | -34.34% |
| EBIT Margin | -103.05% |
| FCF Margin | n/a |
Dividends & Yields
Dextech Medical AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.68% |
| Shareholder Yield | -0.68% |
| Earnings Yield | -5.61% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |